MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ACRV — Acrivon Therapeutics, Inc. Common Stock
NasdaqAcrivon Therapeutics, Inc. Common Stock
$2.01
-0.04(-1.95%)
- O
- 2.02
- H
- 2.12
- L
- 2.00
- V
- 315.65K
⏱️ End-of-day dataAs of Oct 1, 2026
ACRV — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $34.06M | $41.50M | $35.41M | $41.90M | N/A | N/A |
| Other Short Term Investments | $63.67M | $77.08M | $93.85M | $95.53M | N/A | N/A |
| Other Current Assets | $1.48M | $1.86M | $1.11M | 989,000.00 | N/A | N/A |
| Total Current Assets | $99.22M | $12.04M | $13.04M | $13.84M | N/A | N/A |
| Properties | $2.25M | $2.53M | $2.79M | $3.05M | N/A | N/A |
| Machinery Furniture Equipment | $7.44M | $7.29M | $6.90M | $6.58M | N/A | N/A |
| Construction In Progress | 916,000.00 | 916,000.00 | $1.24M | $1.10M | N/A | N/A |
| Accumulated Depreciation | $-3.70M | $-3.32M | $-2.96M | $-2.61M | N/A | N/A |
| Other Non Current Assets | $1.70M | $1.86M | $1.85M | $1.85M | N/A | $1.65M |
| Total Non Current Assets | $8.61M | $9.27M | $14.94M | $20.17M | N/A | N/A |
| Total Assets | $10.78M | $12.97M | $14.53M | $15.86M | N/A | N/A |
| Accounts Payable | $1.16M | $2.28M | 996,000.00 | $1.16M | $3.69M | 758,000.00 |
| Accrued Expenses | $6.57M | $6.66M | $8.32M | $7.94M | N/A | N/A |
| Short Term Debt | $1.15M | $1.17M | $1.18M | $1.15M | N/A | N/A |
| Pensions | $2.17M | $5.56M | $4.39M | $3.18M | N/A | N/A |
| Total Current Liabilities | $11.05M | $15.66M | $14.89M | $13.43M | N/A | N/A |
| Long Term Debt | $1.26M | $1.54M | $1.80M | $2.12M | N/A | N/A |
| Total Non Current Liabilities | $1.26M | $1.54M | $1.80M | $2.12M | N/A | N/A |
| Total Liabilities | $12.32M | $17.20M | $16.70M | $15.55M | $15.96M | $19.80M |
| Common Stock | 38,000.00 | 31,000.00 | 31,000.00 | 31,000.00 | N/A | N/A |
| Retained Earnings | $-29.39M | $-27.49M | $-25.59M | $-23.77M | N/A | N/A |
| Other Shareholders Equity | 4,000.00 | 111,000.00 | 112,000.00 | 106,000.00 | N/A | N/A |
| Total Shareholders Equity | $95.52M | $11.25M | $12.86M | $14.30M | N/A | N/A |
| Additional Paid In Capital | $38.94M | $38.73M | $38.44M | $38.06M | N/A | N/A |
| Investments And Advances | N/A | 0.00 | $5.11M | $10.20M | N/A | N/A |